multiscale modeling: a valuable asset for therapeutics development center for neural engineering...

18
Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Upload: noel-newton

Post on 13-Jan-2016

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Multiscale Modeling: A Valuable Asset for Therapeutics Development

Center for Neural EngineeringJean-Marie C. Bouteiller

Theodore W. Berger

Sept. 9, 2015

Page 2: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Multiscale Nature of the Nervous System

Temporal Scale

Spati

al S

cale

mse

c

min yrs

nm

mm

m

Electrophysiology

Neurodegenerative diseases

Behavior Imaging

Experimental ParadigmObservable

Long Term Potentiation

Isolated characterization

Page 3: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Modeling of the Nervous System

3

Elementary Objects of the Nervous System (EONS):

EONS is a detailed parametric (mechanistic) model of the biomolecular mechanisms that take place at the synaptic scale.

Page 4: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Modeling of the Nervous SystemElementary Objects of the Nervous System (EONS):

Page 5: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Example of Application (1)Combinations: Given X compounds, identify a combination of 2 potential synergistic compounds, and their optimal concentrations

5

In-Vitro Validation:

In-Silico Prediction:

Page 6: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

… From Synapse…

6

Page 7: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

… From Synapse… to Neuron Level

7

Page 8: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Example of Application (2)Study of the effects of Glutamatergic and Gabaergic Molecular Dynamics Modulation on Neuronal Spiking

Excitatory synapse Inhibitory synapse

Excitatory Receptor

CA1 pyramidal Cell

Compound

Target

Subcellularcompartment

Cell

Inhibitory receptor

IPSPEPSP

EPSC IPSC

Page 9: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Example of Application (2)Study of the effects of Glutamatergic and Gabaergic Molecular Dynamics Modulation on Neuron Spiking Activity

NMDA receptor inhibition (AP5):

(Ambert et al. Open Access Bioinformatics 2010)

Binding

Page 10: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Example of Application (2)

GABA A receptor inhibition (bicuculline):

GABA A dynamic response

Study of the effects of Glutamatergic and Gabaergic Molecular Dynamics Modulation on Neuron Spiking Activity

Page 11: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Example of Application (2)Study of the effects of Glutamatergic and Gabaergic Molecular Dynamics Modulation on Neuron Spiking ActivitySynaptic Level

11

Neuronal Integration

*: New spikes with respect to control -: Spikes removed with respect to control

Time (ms)

Page 12: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

… From Neuron…

12

Page 13: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

… From Neuron… to Network

13

Page 14: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Summary

Multiscale In-Silico Models can provide insights on nervous system function and dysfunctions

14

Page 15: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Summary

Multiscale In-Silico Models can provide insights on nervous system function and dysfunctions

They can guide development of potential therapeutics Study of combinations Therapeutics efficacy Side Effects, toxicity

15

Page 16: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Summary

Multiscale In-Silico Models can provide insights on nervous system function and dysfunctions

They can guide development of potential therapeutics Study of combinations Therapeutics efficacy Side Effects, toxicity

Challenges preventing adoption of this technology

16

Page 17: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

Summary

Multiscale In-Silico Models can provide insights on nervous system function and dysfunctions

They can guide development of potential therapeutics Study of combinations Therapeutics efficacy Side Effects, toxicity

Challenges preventing adoption of this technology

17

Our brain:(i) To structure

complexity

(ii) Address actual needs

(problem driven)

Non-believers’ brain:After many other fields,

biology and medicine are next…

… It is just a matter of when.

Page 18: Multiscale Modeling: A Valuable Asset for Therapeutics Development Center for Neural Engineering Jean-Marie C. Bouteiller Theodore W. Berger Sept. 9, 2015

End.

Acknowledgments

Theodore W. Berger, PhDDong Song, PhD

Eric Hu Sushmita Allam, PhD

Mike Huang

Endre T. Somogyi, PhD (IU, Bloomington)Herbert Sauro, PhD (UW, Seattle)

Serge Bischoff, PhDMichel Baudry, PhD

Funding:P41 EB001978-24

U01 GM104604